Evidence map›Paper›PMID 12493839›Full record

ArticleProtein science : a publication of the Protein Society2003

Leucine 145 of the ribotoxin alpha-sarcin plays a key role for determining the specificity of the ribosome-inactivating activity of the protein.

Manuel Masip, Lucía García-Ortega, Nieves Olmo, Maria Flor García-Mayoral, José Manuel Pérez-Cañadillas, Marta Bruix, Mercedes Oñaderra, Alvaro Martínez del Pozo, José G Gavilanes

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Manuel MasipDepartamento de Bioquímica y Biología Molecular, Facultad de Química, Universidad Complutense, 28040-Madrid, Spain.
Lucía García-Ortega
Nieves Olmo
Maria Flor García-Mayoral
José Manuel Pérez-Cañadillas
Marta Bruix
Mercedes Oñaderra
Alvaro Martínez del Pozo
José G Gavilanes
Universidad Complutense de Madrid · ESConsejo Superior de Investigaciones Científicas · ESInstituto de Química Física Blas Cabrera · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secreted fungal RNases, represented by RNase T1, constitute a family of structurally related proteins that includes ribotoxins such as alpha-sarcin. The active site residues of RNase T1 are conserved in all fungal RNases, except for Phe 100 that is not present in the ribotoxins, in which Leu 145 occupies the equivalent position. The mutant Leu145Phe of alpha-sarcin has been recombinantly produced and characterized by spectroscopic methods (circular dichroism, fluorescence spectroscopy, and NMR). These analyses have revealed that the mutant protein retained the overall conformation of the wild-type alpha-sarcin. According to the analyses performed, Leu 145 was shown to be essential to preserve the electrostatic environment of the active site that is required to maintain the anomalous low pKa value reported for the catalytic His 137 of alpha-sarcin. Enzymatic characterization of the mutant protein has revealed that Leu 145 is crucial for the specific activity of alpha-sarcin on ribosomes.

Indexed as

Fungal ProteinsAmino Acid SubstitutionBinding SitesCircular DichroismEndoribonucleasesFungiHot TemperatureHumansHydrogen-Ion ConcentrationInhibitory Concentration 50LeucineModels, MolecularProtein ConformationProtein DenaturationRhabdomyosarcomaRibosomesalpha-sarcinEndoribonucleasesFungal ProteinsLeucineRNA, Ribosomal

Identifiers

PMID12493839
PMCPMC2312396
OpenAlexW2129612276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.